Blog, Summary15 Steve Hoffman Blog, Summary15 Steve Hoffman

Trump Signs EO on Regenerative Agriculture While EPA Approves More Toxic Forever Chemicals

This article first appeared in the August 2026 issue of Presence Marketing’s newsletter.

By Steven Hoffman

The summer of 2026 has delivered a dizzying regulatory whiplash for the natural, organic, and regenerative agriculture industry. On one hand, the phrase "regenerative agriculture" has officially reached the highest echelons of federal policy, recently enshrined in a presidential executive order and championed loudly under the populist "Make America Healthy Again" (MAHA) banner.

On the other hand, a quiet but aggressive rollout of toxic synthetic "forever chemicals," deep cuts to public health and agricultural inspection funding, and sweeping executive and legal victories for the agrochemical lobby tell a starkly different story.

For business owners, executives, and retailers in the natural and organic products sector, this legislative and regulatory environment presents a highly volatile mixed bag. We are witnessing a fundamental tension between the administration's public health rhetoric and its actual regulatory execution. As consumers increasingly look to the natural channel for transparency and safety, understanding these seismic shifts is critical. 

Here is a comprehensive look at how recent federal actions, courtroom reversals, and public health fallouts are redefining the business of food and agriculture from the soil to the shelf.

The Biofuel Pivot: Is It True Regenerative Agriculture?
On June 25, 2026, President Donald Trump signed Executive Order 14414, formally titled Advancing Regenerative Agriculture and Strengthening American Farm Resilience. The directive instructs the U.S. Department of Agriculture (USDA), the Environmental Protection Agency (EPA), and Health and Human Services (HHS) to expand precision farming, streamline agricultural innovation, and evaluate cumulative chemical exposures in the food supply.

Simultaneously, USDA Secretary Brooke Rollins introduced a final Regenerative Feedstock Rule. Rather than injecting expansive new government subsidies into direct federal conservation or organic transition programs, the administration’s approach is entirely market-driven. As detailed by the Western Ag Network, the new USDA framework ties directly into the 45Z Clean Fuel Production Tax Credit, utilizing an updated "Feedstock Carbon Intensity Calculator" to connect on-farm practices with biofuel supply chains.

In practice, this allows massive conventional corn, soybean, and sorghum producers to document specific farming practices—such as no-till or cover cropping—and market their harvests at a premium to ethanol and biofuel producers. The goal is to incentivize carbon reduction without imposing federal mandates.

While market-based incentives for carbon reduction sound promising, advocates and organic farmers are raising the alarm. Many view this framework as a blatant co-opting of the regenerative movement by Big Ag. True regenerative agriculture—as pioneered by the organic movement—focuses on eliminating toxic inputs, restoring biodiversity, and building soil health to grow nutrient-dense food. Critics argue that the administration is simply repackaging the term "regenerative" into a carbon-scoring mechanism to subsidize industrial biofuel production, all while continuing to allow the use of synthetic pesticides and fertilizers on those very same crops. For natural products retailers, this underscores the urgent need to differentiate true regenerative organic food from conventional crops participating in carbon tax credit programs.

Funding Volatility and a Courtroom Rebuke
This pivot toward corporate biofuel subsidies has been accompanied by aggressive cuts to programs meant to support small-scale and marginalized farmers.

The administration’s new executive order did not add net-new financial outlays; rather, it shifted approximately $700 million within existing agency budgets to fund its new pilot programs. To balance the books and fulfill a mandate to eliminate what it deemed wasteful spending and "diversity, equity, and inclusion (DEI)" initiatives, the USDA abruptly canceled the Increasing Land, Capital, and Market Access Program (ILCMA) earlier this year. Originally a $300 million initiative to help Black, Native American and historically underserved farmers secure land and financing, the program was canceled earlier this year over alleged administrative and DEI-related concerns.

However, the administration’s aggressive funding cuts recently hit a major legal wall. On June 30, U.S. District Judge Beryl Howell granted a preliminary injunction ordering the USDA to restore $127 million in canceled grants to 24 organizations while litigation continues. The plaintiffs successfully argued that the USDA unlawfully terminated the awards based on arbitrary keyword searches rather than on performance or merit. This courtroom rebuke is a massive victory for grassroots agricultural groups and reinforces the USDA's legal obligation to honor its contracts with the young and first-generation farmers who represent the future of the nation’s specialized food supply.

In another piece of rare, positive news for the natural products sector, the USDA recently announced that the organic certification cost-share funds have finally been released. These funds are a vital lifeline for small- to mid-sized organic operations, reimbursing them for a portion of the financial burden required to maintain their rigorously audited USDA Organic certifications. The release of these funds will help stabilize the organic supply chain as farmers finalize their operational budgets for the coming year.

#ChemGate and PFAS Proliferation
While the administration touts its commitment to farm resilience, its environmental regulatory arm is moving in a dangerously contradictory direction.

In early July 2026, the EPA quietly fast-tracked the approval of three new toxic pesticides containing PFAS (per- and polyfluoroalkyl substances)—commonly known as "forever chemicals." The hazardous new herbicides—trifludimoxazin, diflufenican, and epyrifenacil—can now be sprayed directly on major food crops, including wheat and citrus. According to the Environmental Working Group (EWG), EPA scientists themselves flagged one of these chemicals as having "suggestive evidence of carcinogenic potential."

This decision brings the total number of PFAS pesticides greenlit by the current EPA to five in under two years. These chemicals do not break down in the environment; they accumulate in the soil, the water table, and ultimately, the human bloodstream, where they are linked to immune system suppression and severe reproductive health issues.

The regulatory failure extends to the FDA, which recently refused a formal petition to set strict limits on forever chemicals in food, leaving consumers entirely unprotected from the downstream effects of the EPA's pesticide approvals.

Food industry visionary and financial analyst Robyn O’Brien has aptly dubbed this crisis "#ChemGate." O'Brien warns that when regulatory bodies become hopelessly captured by the chemical lobbying arms they are meant to oversee, the entire integrity of the American food supply collapses. For natural products retailers, the EPA's quiet unleashing of forever chemicals onto conventional produce serves as the ultimate marketing imperative for the organic seal. As conventional agriculture becomes increasingly saturated with indestructible synthetic toxins, the rigorously audited, “no toxic synthetic pesticides” promise of the organic aisle transforms from a premium lifestyle choice into a fundamental public health necessity.

The Glyphosate Betrayal: A Fracture in the MAHA Alliance
The tension between the populist MAHA movement and the administration’s actual policy execution reached a breaking point this year over the world’s most notorious herbicide: glyphosate.

The fracture began in February 2026 when President Trump issued an executive order invoking the Defense Production Act to mandate and protect the domestic production of glyphosate (the active ingredient in Roundup), citing national security and food supply chain resilience. The order granted broad liability immunities, infuriating MAHA advocates who had championed the administration on the promise of health reform. As Environmental Working Group President Ken Cook noted at the time, the move was viewed by many wellness advocates as a "direct assault" on the MAHA platform and a great gift to the chemical lobby.

This administrative protection was recently compounded by a landmark decision from the nation's highest court. This summer, the U.S. Supreme Court ruled in favor of agrochemical giant Bayer regarding its glyphosate-based weedkiller. The ruling effectively blocks thousands of state-level "failure-to-warn" lawsuits, determining that federal EPA label approvals preempt state laws that might otherwise require cancer-warning labels on toxic pesticides.

This decision essentially grants a liability shield to pesticide manufacturers, protecting them from plaintiffs alleging they were not properly informed about the severe health risks associated with chronic glyphosate or other chemical pesticide exposure.

For the MAHA movement, the executive protections and the Supreme Court ruling exposed a deep rift between the political rhetoric of "making America healthy" and a regulatory reality that actively insulates the chemical agriculture industry from legal consequence. As reported by Grist, attempts to appease MAHA's fury over the Roundup rulings have largely backfired, leaving health-freedom advocates feeling profoundly betrayed. Protests have taken place outside the Supreme Court, signaling that the coalition of health advocates that helped propel the administration into office is fracturing over its failure to regulate Big Chem.

The Public Health Fallout: The Cost of Cutbacks
The consequences of prioritizing corporate deregulation and cutting federal research and inspection budgets are not abstract; they are already playing out in real time across the nation's supply chains and emergency rooms.

The current administration has initiated historic cutbacks in public health funding, FDA food inspections, and USDA agricultural research. The result is a regulatory apparatus that is operating with severe blind spots, and the public is paying the price.

In recent weeks, an explosive food-borne Cyclospora outbreak has swept across the United States, causing severe, prolonged gastrointestinal illness. Cyclospora is a microscopic parasite transmitted through feces and typically linked to contaminated fresh produce. As of July 2026, the parasite has sickened thousands of Americans across at least 34 states, with the Midwest bearing the brunt of the crisis. In Ohio, the Cleveland Clinic reported a staggering jump in lab testing, skyrocketing from just one test per day to nearly 200 as symptomatic patients flooded local hospitals.

The federal response has been heavily hindered by recent agency rollbacks. Due to severe staffing shortages and budgetary cuts at the Centers for Disease Control and Prevention (CDC)—which recently made the tracking of certain foodborne illnesses optional—federal case data has drastically lagged behind real-time state-level reporting. Without a robust, centralized federal tracing apparatus, state health investigators have been left to piece together the puzzle on their own. While early interviews strongly point to lettuce and salad greens as the leading suspected source, a specific grower, brand, or supplier has yet to be definitively named by federal authorities.

As local health departments scramble to track the outbreak's expanding footprint across the country, this unresolved crisis raises grave questions about the ability of gutted federal agencies to adequately monitor the safety of the conventional food supply. When the government can no longer proactively track and trace a pathogen, the burden of food safety falls entirely on the retailer and the private supply chain.

Simultaneously, the agricultural sector is battling a devastating screwworm outbreak affecting livestock. For decades, the USDA successfully managed the threat of the New World screwworm—a parasite that feeds on the living tissue of warm-blooded animals—through robust research and sterile insect release programs. However, recent reductions in federal research funding and the mass exodus of USDA researchers who are refusing mandatory relocations have compromised the agency's ability to maintain these critical biological defense lines, resulting in a crisis for ranchers and a direct threat to the meat supply chain.

The Strategic Path Forward for the Natural Channel
As we survey the current landscape, the mandate for the natural, organic and regenerative products industry is unmistakably clear. We can no longer rely on federal tailwinds, government definitions, or public safety nets to protect our consumers or our food supply.

When the federal government co-opts the term "regenerative" to subsidize industrial biofuels, unleashes PFAS forever chemicals onto conventional crops, shields glyphosate manufacturers from liability, and defunds the agencies responsible for keeping parasites out of our produce, the conventional food system ceases to be a safe default for the American family.

In this environment of deep institutional failure, the natural products channel stands as the last line of defense.

Retailers, brands and investors must step into the regulatory void and double down on uncompromising transparency. We have an opportunity to educate customers on the profound difference between a federally subsidized "regenerative" biofuel crop and rigorously audited USDA Certified Organic and Regenerative Organic Certified (ROC) food systems.

Furthermore, private capital must continue to step forward. To truly scale clean agriculture, the private sector needs to prioritize funding the organic transitions, the local supply chain infrastructure, and the independent agricultural research that the federal government is actively abandoning.

The agricultural policies of 2026 are indeed a mixed bag—heavy on chemical appeasement and light on actual public health reform. But out of this chaos emerges a profound opportunity. As the conventional system compromises itself, the value proposition of the natural, organic, regenerative, and specialty food industry has never been more vital, more distinct or more essential to the future of human health and environmental resilience.

Steven Hoffman is Managing Director of Compass Natural Marketing, a strategic communications and brand development agency serving the natural and organic products industry. Learn more at www.compassnatural.com.

Read More
Blog, Summary15 Steve Hoffman Blog, Summary15 Steve Hoffman

2026 Federal Hemp Ban: Understanding the Legislative Paradox Reshaping the Consumable Hemp Market

This article first appeared in the July 2026 issue of Presence Marketing’s newsletter.

By Steven Hoffman

For years, the natural products industry has served as the tip of the spear for plant-based wellness and agricultural innovation. Independent health food stores, natural grocery chains and co-ops were among the first to educate American consumers on the endocannabinoid system. They were the pioneers who brought hemp-derived CBD to the mainstream, championing a botanical remedy that offered millions relief from pain, anxiety and inflammation without the intoxicating effects of traditional marijuana.

Thanks to the 2018 Farm Bill, which legalized commercial hemp cultivation, a vibrant supply chain emerged. From the regenerative organic farmer cultivating the crop to the innovative manufacturer formulating tinctures and topicals, to the retailer curating wellness aisles, the hemp economy blossomed into a formidable market. According to Inc. Magazine, the hemp sector is now valued at a staggering $28.4 billion, supporting more than 300,000 jobs nationwide.

Yet, as we move through the summer of 2026, this thriving ecosystem faces an existential threat. A looming federal ban, passed quietly as a rider in a 2025 appropriations bill, threatens to decimate the consumable hemp market by the end of the year.

At the exact moment the federal government is taking historic steps to deregulate and reschedule marijuana, it is simultaneously moving to criminalize the non-intoxicating, therapeutic hemp products that natural products retailers have safely sold for years. For business owners, executives, and professionals in the natural and organic food market, understanding the mechanics of this ban, the paradox of federal cannabis policy, and the ongoing fight for agricultural seed sovereignty is critical to navigating the turbulent months ahead.

Section 781 and the November 12 Deadline
The crisis stems from the Appropriations Act for 2026, signed into law on Nov. 12, 2025, to end a government shutdown. Buried within the legislation was Section 781, a provision orchestrated largely by Representative Andy Harris (R-MD), who presides over the House Appropriations Subcommittee on Agriculture, and bolstered by the legislative weight of Senator Mitch McConnell (R-KY), that fundamentally redefines legal hemp in the United States.

Under the 2018 Farm Bill, hemp was defined as cannabis containing less than 0.3% delta-9 THC on a dry-weight basis. Beyond the promise of food and fiber products derived from hemp, this definition allowed for the proliferation of full-spectrum CBD products, which naturally contain trace amounts of THC. However, it also created a loophole that allowed chemists to synthesize intoxicating cannabinoids—like delta-8 THC and THCA—from legal hemp CBD, leading to a flood of unregulated, intoxicating products in convenience stores and gas stations across the country.

Rather than creating a robust regulatory framework to address synthetic intoxicants, Congress opted for a blunt instrument. As detailed by Vicente LLP, Section 781 shifts the definition of hemp to a "total THC standard" (0.3% total THC, inclusive of THCA and delta-8). More devastatingly, the law caps final-form hemp-derived cannabinoid products at a microscopic 0.4 milligrams of total THC per container.

Absent intervening legislation, this restrictive standard takes effect on Nov. 12, 2026. Because even non-intoxicating, full-spectrum CBD products naturally contain more than 0.4 milligrams of trace THC per container, the new law essentially throws the baby out with the bathwater. According to the U.S. Hemp Roundtable, the ban will render approximately 95% of existing hemp-derived cannabinoid products federally unlawful.

As Forbes recently noted, the new rules will knock out popular, non-intoxicating CBD products that consumers rely on daily. For natural products retailers, this means that the tinctures, gummies, and functional beverages currently driving significant foot traffic and revenue will likely become contraband overnight. According to Recovered.org, the law will stringently restrict the possession and sale of these products, particularly in states where marijuana remains illegal.

Retailers and Producers Raise the Alarm
The impending ban has sent shockwaves through the natural products supply chain. Retailers who meticulously vetted brands for organic certification, clean extraction methods and third-party testing are now facing the prospect of emptying their shelves of CBD products.

Local businesses and wellness practitioners are raising the alarm, arguing that federal policymakers have fundamentally misunderstood the products they are banning. "We have the backing of medical professionals in Lancaster, in Pennsylvania, and across the country that refer their patients to us for pain relief," Heather Kreider, owner of Hempfield Botanicals in Lancaster, PA, told Fox43. "I'm a registered nurse myself. I'm also a cannabis educator, so I take what we do here very seriously. We're doing the right things here; however, those bad players are not, and they're the ones that are causing the issues."

The collateral damage extends beyond the retail sector and into federal healthcare initiatives. As reported by The Guardian, the hemp ban will effectively derail a highly anticipated Medicare pilot program designed to reimburse seniors for hemp-derived products. The model program, which launched just months ago, covered up to $500 per year for eligible Medicare patients utilizing CBD products. The federal ban undermines this progress entirely, cutting off affordable access to natural wellness for vulnerable populations.

As the Alliance for Natural Health argues, the ban is "built on broken science." By targeting the trace, naturally occurring cannabinoids in full-spectrum hemp, the government is effectively outlawing a botanical medicine that millions of Americans rely upon daily.

The Marijuana Rescheduling Paradox
Perhaps the most bewildering aspect of the 2026 federal hemp ban is the stark policy contradiction it creates within the broader cannabis landscape.

While the federal government is lowering the hammer on non-intoxicating hemp products, it is simultaneously taking historic steps to deregulate traditional, high-THC marijuana. In recent months, federal agencies have moved to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act, recognizing its medical utility and reducing tax burdens for state-licensed dispensaries.

This creates a jarring paradox for grocery retailers and natural food vendors: The federal government is facilitating the growth of the intoxicating, highly regulated dispensary market while actively criminalizing the non-intoxicating hemp market historically sold in mainstream grocery aisles.

Reason magazine recently highlighted this hypocrisy, noting that Mitch McConnell's push for the hemp ban betrays the very industry he helped create through the 2018 Farm Bill. The prohibition destroys a thriving industry to solve a regulatory issue that individual states were already handling effectively.

The backlash against this paradox has prompted unexpected political alliances. In April 2026, President Donald Trump took to Truth Social to push Congress to save the industry. Following his administration's historic moves to protect medical marijuana, Trump stated he was calling on Congress to update the law "to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on ... while preserving Congress’s intent to restrict the sale of products that pose health risks."

Seed Sovereignty: The Hidden Threat of Section 781
While the consumer impact of the hemp ban has dominated the headlines, Section 781 contains a more insidious threat to agriculturalists: the erosion of seed sovereignty.

In the regenerative agriculture and organic farming communities, seed sovereignty—the right of farmers to save, breed, and exchange seeds free from corporate or government overreach—is a sacred tenet. Yet, the new federal definitions deeply compromise this right. As detailed by Grow Weed Easy, the new federal hemp and cannabis seed law dictates that viable seeds from high-THC plants are explicitly excluded from the definition of legal hemp, even if the seeds themselves contain zero THC.

This linguistic shift in the federal code has profound implications. Green State reports that this little-known federal rule could effectively make vast swaths of cannabis seeds illegal, paralyzing the nation's seed banks, agricultural research institutions, and independent farmers. Local businesses are already feeling the chilling effect. In Maine, the Fairfield Hemp Seed Company warned that the federal bill could lead to their closure, stripping farmers of access to reliable, region-specific genetics

Leading the charge against this agricultural overreach is the American Seed Innovation & Genetics Association (ASIGA). In a comprehensive white paper regarding Section 781, ASIGA meticulously outlines how the government's conflation of mature plant cannabinoids with the genetic potential of a seed stifles agricultural innovation.

By criminalizing seeds based on their potential future THC expression rather than on their current chemical makeup, the federal government is erecting massive barriers to entry for independent breeders. ASIGA argues that seeds are the essential foundation of agricultural diversity. Without the legal protection to trade and cultivate diverse cannabis genetics, the industry risks consolidating into the hands of a few well-capitalized, multi-state operators, directly contradicting the anti-monopoly ethos of the natural products industry. For organizations championing seed sovereignty and legal clarity, repealing or amending Section 781 is not just about saving CBD gummies; it is about defending a farmer's fundamental right to the seed.

The Legislative Scramble: Will Congress Intervene?
With the November 12 deadline approaching, the hemp industry has launched a desperate legislative scramble to save itself.

Several lawmakers have attempted to introduce rescue measures. In the House, Rep. James Comer (R-KY) and Rep. Andy Barr (R-KY)  introduced bills and amendments aimed at establishing a comprehensive regulatory framework or delaying the ban entirely. Three U.S. House Republicans recently attempted to thwart the intoxicating hemp product ban during Farm Bill negotiations, and another GOP lawmaker is currently circulating a bill to keep hemp THC drinks federally legal. Furthermore, the intoxicating hemp industry is actively seeking a rescue in Congress.

However, the political reality is grim. Despite bipartisan lobbying efforts, the U.S. Congress has repeatedly blocked the latest rescue attempts. According to Marijuana Moment, top marijuana reform groups concede that Congress is unlikely to prevent the new federal ban this year.

The broader cannabis industry finds itself fractured. Some stakeholders in the licensed marijuana dispensary space view the hemp ban as a victory, eliminating competition from unregulated hemp-derived products. As Hemp Today reports, bipartisan lobbyists have joined the cynical cause as intoxicating hemp faces its endgame, resulting in a situation where the federal axe is finally falling on intoxicating hemp.

Unfortunately, the collateral damage of this infighting is the natural and organic food retailer, the hemp farmer, and the consumer relying on full-spectrum CBD.

How Retailers and Brands Can Prepare
As we stare down the barrel of November 2026, business leaders in the natural products sector must be pragmatic. Hoping for a last-minute congressional miracle is not a viable business strategy.

While the question of which products will disappear under the national hemp ban remains unanswered pending potential enforcement guidance, retailers and manufacturers must audit their supply chains immediately. Brands should consult with legal counsel to understand their exposure to the 0.4-milligram total THC limit per container. Retailers must review their vendor agreements and prepare for significant SKU rationalization in their wellness aisles.

However, as MJBiz Daily astutely points out, hemp THC regulation is inevitable, but it’s not a ban—and operators must prepare. The natural products industry must pivot from reacting to prohibition to actively advocating for intelligent, science-based regulation. This means supporting organizations like ASIGA in the fight for seed sovereignty, and aligning with groups like the U.S. Hemp Roundtable and others to demand strict age restrictions on sales (age-gating), cGMP manufacturing standards, and truthful labeling over outright bans.

The natural products sector is no stranger to navigating complex regulatory shifts, and while retailers will ultimately adapt to the loss or transformation of a popular wellness category, the 2026 Federal Hemp Ban poses a genuine threat to the farmers, formulators, and producers who built the $28 billion consumable hemp products market. Moving forward, the survival of the consumable hemp sector depends not on a return to the unregulated gray market, but on a unified industry push for sensible, safety-focused legislation. By advocating for mandatory age verification, stringent manufacturing standards and seed sovereignty rather than blunt prohibition, the trade can chart a sustainable path forward—one that protects consumers, preserves retail revenue streams, and defends the agricultural innovators who supply them.

Steven Hoffman is Managing Director of Compass Natural Marketing, a strategic communications and brand development agency serving the natural and organic products industry. Learn more at www.compassnatural.com.

Read More